“ENPP1 Suppresses Anticancer cGAMP-STING Pathway in Breast Cancer: Potential of ENPP1 Blockade as Therapeutic Approach”

https://pubmed.ncbi.nlm.nih.gov/38117852

The study identifies ENPP1 as a key suppressor of the anticancer cGAMP-STING pathway in breast cancer, and suggests that ENPP1 blockade could be a promising therapeutic approach for controlling local activation of STING and treating breast cancer.